8102
-
Therapeutics and Clinical Risk Management
-
About Dovepress
Open access peer-reviewed scientific and medical journals.
-
Open Access
Dove Medical Press is now a member of the Open Access Initiative
-
An Author's Guide
A guide to help authors get their paper published.
-
Advocacy
Support Open Access and Dove Press
-
Reprints
Promotional Article Monitoring - further details
-
Favored Author Program
Real benefits for authors, including fast-track processing of papers.
Therapeutics and Clinical Risk Management
(2,215,712) Views
Editor in Chief Professor Garry Walsh
1178-203X
Effect of patient-specific factors on weekly warfarin dose
Heather P Whitley, Joli D Fermo, Elinor CG Chumney, Walter Adam Brzezinski
Therapeutics and Clinical Risk Management 2007, 3:499-504
14 August 2007
The use of antithrombotics in patients presenting with stroke and atrial fibrillation
Carl Burgess, Tristram Ingham, Martin Woodbridge, Mark Weatherall, Michael Nowitz
Therapeutics and Clinical Risk Management 2007, 3:491-498
14 August 2007
Detection and remediation of medically urgent situations using telemedicine case management for older patients with diabetes mellitus
Roberto Izquierdo, Suzanne Meyer, Justin Starren, Robin Goland, Jeanne Teresi, et al
Therapeutics and Clinical Risk Management 2007, 3:485-489
13 May 2007
Creating diagnostic scores using data-adaptive regression: An application to prediction of 30-day mortality among stroke victims in a rural hospital in India
Merrill D Birkner, SP Kalantri, Vaishali Solao, Priya Badam, Rajnish Joshi, Ashish Goel, Madhukar Pai, Alan E Hubbard
Therapeutics and Clinical Risk Management 2007, 3:475-484
14 August 2007
Rasagiline – a novel MAO B inhibitor in Parkinson’s disease therapy
Shimon Lecht, Simon Haroutiunian, Amnon Hoffman, Philip Lazarovici
Therapeutics and Clinical Risk Management 2007, 3:467-474
14 August 2007
Zanamivir for the prevention of influenza in adults and children age 5 years and older
Lea S Eiland, Edward H Eiland
Therapeutics and Clinical Risk Management 2007, 3:461-465
14 August 2007
Acute migraine: Current treatment and emerging therapies
Arun A Kalra, Debra Elliott
Therapeutics and Clinical Risk Management 2007, 3:449-459
14 August 2007
Treatment of community-acquired pneumonia, with special emphasis on gemifloxacin
Serkan Öncü
Therapeutics and Clinical Risk Management 2007, 3:441-448
14 August 2007
Recombinant human epoetin beta in the treatment of renal anemia
Francesco Locatelli, Pietro Pozzoni, Lucia Del Vecchio
Therapeutics and Clinical Risk Management 2007, 3:433-439
14 August 2007
A review of the role of capecitabine in the treatment of colorectal cancer
Pasquale Comella
Therapeutics and Clinical Risk Management 2007, 3:421-431
14 August 2007
The safety and efficacy of alefacept in the treatment of chronic plaque psoriasis
Claudia Jenneck, Natalija Novak
Therapeutics and Clinical Risk Management 2007, 3:411-420
14 August 2007
Tramadol extended-release in the management of chronic pain
Bill McCarberg
Therapeutics and Clinical Risk Management 2007, 3:401-410
14 August 2007
Current approach to cancer pain management: Availability and implications of different treatment options
Hrachya Nersesyan, Konstantin V Slavin
Therapeutics and Clinical Risk Management 2007, 3:381-400
14 August 2007
A review of rabeprazole in the treatment of acid-related diseases
Fabio Pace, Stefano Pallotta, Stefania Casalini, Gabriele Bianchi Porro
Therapeutics and Clinical Risk Management 2007, 3:363-379
14 August 2007
Editorial || FREE PAPER ||
Garry M Walsh
Therapeutics and Clinical Risk Management 2007, 3:361-362
14 August 2007
- Have an opinion about one of our articles?
We encourage you to write a Letter to the Editor
- American Acne and Rosacea Society
The American Acne and Rosacea Society (AARS), is a 501(c)(6) non-profit organization dedicated to elevating the understanding and treatment of acne and rosacea.
